drugset / Trial / NCT01689363

Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)

NCT01689363

Phase 2 Completed 253 enrolled Amphastar Pharmaceuticals, Inc.
RandomizedCrossoverTriple-blindScreening

Summary

This study is designed to evaluate the allergenicity of Amphadase® in healthy volunteers using an intradermal skin test.

Timeline

Start
2012-09
Primary completion
2012-11
Completion
2012-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject rHuPH20 Protein / enzyme biologic 0.02 ml Other
Subject rHuPH20 Protein / enzyme biologic 150 iu Other
Comparator Histamine Small molecule 0.02 ml Other
Comparator Histamine Small molecule 0.1 mg/ml Other